• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope.治疗耐多药结核病的更短、更廉价方案：新希望
Indian J Med Res. 2017 Sep;146(3):301-303. doi: 10.4103/ijmr.IJMR_1704_16.
2
BPaL approved for multidrug-resistant tuberculosis.BPaL方案被批准用于治疗耐多药结核病。
Lancet Infect Dis. 2019 Oct;19(10):1063-1064. doi: 10.1016/S1473-3099(19)30489-X.
3
Bedaquiline.贝达喹啉
Br J Clin Pharmacol. 2015 Aug;80(2):182-4. doi: 10.1111/bcp.12613. Epub 2015 Jul 2.
4
Rapid emergence of bedaquiline resistance: lessons to avoid repeating past errors.贝达喹啉耐药性的迅速出现：避免重蹈覆辙的教训。
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.01719-2016. Print 2017 Mar.
5
Current issues with the use of bedaquiline.使用贝达喹啉的当前问题。
Ann Pharmacother. 2014 May;48(5):666. doi: 10.1177/1060028014521589. Epub 2014 Feb 11.
6
Reply to comments by Kakkar and Dahiya.对卡卡尔和达希亚评论的回复。
Ann Pharmacother. 2014 May;48(5):667. doi: 10.1177/1060028014521590.
7
Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis.贝达喹啉与地拉曼尼联合治疗耐药结核病。
Lancet Infect Dis. 2019 May;19(5):470. doi: 10.1016/S1473-3099(19)30168-9.
8
Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.对抗耐药结核病：贝达喹啉的意外益处
Int J Tuberc Lung Dis. 2017 Jan 1;21(1):4-5. doi: 10.5588/ijtld.16.0768.
9
Bedaquiline or delamanid for rifampin-resistant tuberculosis?贝达喹啉还是地拉曼尼用于治疗耐利福平结核病？
Lancet Respir Med. 2017 Oct;5(10):772-774. doi: 10.1016/S2213-2600(17)30309-0. Epub 2017 Sep 5.
10
Multidrug-resistant tuberculosis and bedaquiline.耐多药结核病与贝达喹啉
N Engl J Med. 2014 Dec 18;371(25):2436. doi: 10.1056/NEJMc1412235.

引用本文的文献

1
Comparing cost-effectiveness of short-course regimens for drug-resistant tuberculosis treatment in India.印度耐多药结核病短程治疗方案的成本效益比较。
Int J Technol Assess Health Care. 2025 Jul 21;41(1):e48. doi: 10.1017/S0266462325100329.
2
A Comprehensive Review on Long vs. Short Regimens in Multidrug-Resistant Tuberculosis (MDR-TB) Under Programmatic Management of Drug-Resistant Tuberculosis (PMDT).耐药结核病规划管理下多药耐药结核病（MDR-TB）长疗程与短疗程的综合综述
Cureus. 2024 Jan 22;16(1):e52706. doi: 10.7759/cureus.52706. eCollection 2024 Jan.
3
Comparing adherence to MDR-TB treatment among patients on self-administered therapy and those on directly observed therapy: non-inferiority randomized controlled trial.比较自我管理治疗和直接观察治疗的耐多药结核病患者治疗依从性：非劣效性随机对照试验。
Trials. 2023 May 12;24(1):326. doi: 10.1186/s13063-023-07314-z.
4
Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.检测结核分枝杆菌对新药敏感性的能力有限。
Emerg Infect Dis. 2021 Mar;27(3):985-987. doi: 10.3201/eid2703.204418.

本文引用的文献

1
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.喀麦隆针对耐多药结核病患者的12个月治疗方案具有高效性。
Int J Tuberc Lung Dis. 2015 May;19(5):517-24. doi: 10.5588/ijtld.14.0535.
2
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.尼日尔标准化短程耐多药结核病治疗治愈率高：无复发情况。
Int J Tuberc Lung Dis. 2014 Oct;18(10):1188-94. doi: 10.5588/ijtld.13.0075.
3
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.多药耐药结核病患者抗结核药物标准化治疗方案的评估（STREAM）：一项随机对照试验的研究方案
Trials. 2014 Sep 9;15:353. doi: 10.1186/1745-6215-15-353.
4
Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies.耐多药和广泛耐药结核病的管理：证据与争议
Lung India. 2012 Apr;29(2):154-9. doi: 10.4103/0970-2113.95321.
5
Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis.短程、高效、廉价的耐多药结核病标准化治疗方案。
Am J Respir Crit Care Med. 2010 Sep 1;182(5):684-92. doi: 10.1164/rccm.201001-0077OC. Epub 2010 May 4.

Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope.

作者信息

Prasad Rajendra, Gupta Nikhil, Banka Amitabh

机构信息

Department of Pulmonary Medicine, ERA's Lucknow Medical College & Hospital, Lucknow 226 024, Uttar Pradesh, India.

Department of General Medicine, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow 226 024, Uttar Pradesh, India.

出版信息

Indian J Med Res. 2017 Sep;146(3):301-303. doi: 10.4103/ijmr.IJMR_1704_16.

DOI:10.4103/ijmr.IJMR_1704_16
PMID:29355135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5793463/
Abstract
摘要